Investigation of contrast agent dosage for perfusion-weighted MRI;Untersuchungen zur kontrastmitteldosierung bei der perfusionsgewichteten MRT

RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren

Volumn 167, Issue 6, 1997, Pages 599-604

  Erb, G ^b   Benner, T ^a   Heiland, S ^b   Reith, W ^b   Sartor, K ^b   Forsting, M ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

Cerebral perfusion; Dosage; Gd DTPA; MRI; Paramagnetic contrast agent

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ARTICLE; BRAIN PERFUSION; DIAGNOSTIC IMAGING; DOSE RESPONSE; IMAGE QUALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; SIGNAL NOISE RATIO;

ADULT; AGED; BRAIN; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0031437293     PISSN: 09366652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Aronen, H., J. L. Boxerman, I. E. Goldberg, R. M. Weisskoff, J. W. Belliveau, J. M. Provenzale, J. M. Vevea, C. M. Calder, T. A. Campbell, T. J. Brady, B. R. Rosen: Susceptibility-contrast CBV imaging: Optimization of contrast dose and imaging sequences. In: Society of Magnetic Resonance in Medicine. Book of Abstracts 2 (1992) 1129
2. Claussen, C. D., D. Banzer, C. Pfretzschner, W. A. Kalender, W. Schörner: Bolus geometry and dynamics after intravenous contrast medium injection. Radiology 153 (1984) 365-368
3. 2*-weighted MR imaging at 1.5 T. Radiology 176 (1990) 211-220
4. Fisel, C. R., J. L. Ackerman, R. B. Buxton, L. Garrido, J. W. Belliveau, B. R. Rosen, T. J. Brady: MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn. Reson. Med. 17 (1991) 336-347
5. 2*-gewichteten Gradienten-Echo-Sequenzen und KM-Gabe im Bolus. Fortschr. Röntgenstr. 156 (1992) 212-217
6. Heiland, S., M. Forsting, W. Reith, T. Balzer, K. Sartor: Perfusion-weighted magnetic resonance imaging of focal cerebral ischemia: Use of the new paramagnetic contrast agent gadoliniumbutrol. In: Society of Magnetic Resonance Book of Abstracts 2 (1994) 1024
7. Kucharczyk, J., H. Asgari, J. Mintorovitch, Z. Vexler, S. Rocklage, A. Watson, M. Moseley: Cerebrovascular transit characteristics of DyDTPA-BMA and GdDTPA-BMA on normal and ischemic cat brain. Amer. J. Neuroradiol. 14 (1993) 289-296
8. Moseley, M. E., R. Sevick, M. F. Wendland, D. L. White, J. Mintorovitch, H. S. Asgari, J. Kucharczyk: Ultrafast magnetic resonance imaging: Diffusion and perfusion. Can. Assoc. Radiol. J. 42 (1991) 31-38
9. Reith, W., M. Forsting, H. Vogler, S. Heiland, K. Sartor: Early MR detection of experimentally induced cerebral ischemia using magnetic susceptibility contrast agents: Comparison between gadolinium DTPA and iron oxide particles. Amer. J. Neuroradiol. 16 (1995) 53-60
10. Rosen, B. R., J. W. Belliveau, J. M. Vevea, T. J. Brady: Perfusion imaging with NMR contrast agents. Magn. Reson. Med. 14 (1990) 249-265
11. Runge, V. M., J. E. Kirsch, J. W. Wells, C. E. Woodfolk: Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced, steady-state free precession MR-imaging: An animal study. Amer. J. Roentgenol. 160 (1993) 593-600
12. Villringer, A., B. R. Rosen, J. W. Belliveau, J. L. Ackerman, R. B. Lauffer, R. B. Buxton, Y. S. Chao, V. J. Wedeen, T. J. Brady: Dynamic imaging with lanthanide chelates in normal rat brain: contrast due to magnetic susceptibility effects. Magn. Reson. Med. 6 (1988) 164-174